NORTHWEST BIOTHERAPEUTICS INC (NWBO) Free cash flow 2018–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$46.3MFY2025 · since FY2018: -$34.6M → -$46.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.3M | +20.3% |
| FY2024 | -$58.0M | -1.7% |
| FY2023 | -$57.1M | -2.5% |
| FY2022 | -$55.7M | -25.6% |
| FY2021 | -$44.3M | -14.5% |
| FY2020 | -$38.7M | -20.8% |
| FY2019 | -$32.0M | +7.4% |
| FY2018 | -$34.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NWBO financial trends
NWBO RevenueNWBO Net incomeNWBO Net marginNWBO Gross profitNWBO Gross marginNWBO Operating incomeNWBO Operating marginNWBO Operating cash flowNWBO Capital expendituresNWBO Return on equityNWBO Stock buybacksNWBO Dividends paidNWBO Total assetsNWBO Total liabilitiesNWBO Shareholders’ equityNWBO overview →